Back to today’s briefing

Story perspectives

Study Reveals 41% of Cancer Patients Experience Painful Neuropathy

1/30/2025

42 9

Summary

Story summary

A groundbreaking Mayo Clinic study involving over 10,000 patients from 28 countries uncovered that 41.22% suffer from chemotherapy-induced peripheral neuropathy (CIPN). This painful condition, triggered by neurotoxic drugs, disrupts motor and sensory functions. With prevalence differing by region and cancer type, there's an urgent call for personalized pain management strategies and deeper investigation into effective therapies.

1 of 1

Story summary

A groundbreaking Mayo Clinic study involving over 10,000 patients from 28 countries uncovered that 41.22% suffer from chemotherapy-induced peripheral neuropathy (CIPN). This painful condition, triggered by neurotoxic drugs, disrupts motor and sensory functions. With prevalence differing by region and cancer type, there's an urgent call for personalized pain management strategies and deeper investigation into effective therapies.